First Time Loading...

Oncternal Therapeutics Inc
NASDAQ:ONCT

Watchlist Manager
Oncternal Therapeutics Inc Logo
Oncternal Therapeutics Inc
NASDAQ:ONCT
Watchlist
Price: 8.27 USD -2.48%
Updated: Apr 30, 2024

Wall Street
Price Targets

ONCT Price Targets Summary
Oncternal Therapeutics Inc

Wall Street analysts forecast ONCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONCT is 31.28 USD with a low forecast of 25.25 USD and a high forecast of 40.95 USD.

Lowest
Price Target
25.25 USD
205% Upside
Average
Price Target
31.28 USD
278% Upside
Highest
Price Target
40.95 USD
395% Upside

ONCT Last Price Targets
Oncternal Therapeutics Inc

The latest public price target was made on Apr 15, 2024 by Raghuram Selvaraju from H.C. Wainwright , who expects ONCT stock to rise by 239% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Raghuram Selvaraju
H.C. Wainwright
28 USD
Upside 239%
2 weeks ago
Apr 15, 2024
Oncternal Therapeutics (ONCT) PT Lowered to $28 at H.C. Wainwright
StreetInsider
Raghuram Selvaraju
H.C. Wainwright
Price Target 28 USD
Upside/Downside 239%
View Source
Oncternal Therapeutics Inc Competitors:
Price Targets
HPHA
Heidelberg Pharma AG
284% Upside
VCYT
Veracyte Inc
57% Upside
IMRX
Immuneering Corp
820% Upside
302440
SK Bioscience Co Ltd
6% Downside
OVID
Ovid Therapeutics Inc
136% Upside
XBIT
XBiotech Inc
132% Upside
ZEAL
Zealand Pharma A/S
20% Upside
9966
Alphamab Oncology
113% Upside

Revenue
Forecast

Revenue Estimate
Oncternal Therapeutics Inc

The compound annual growth rate of Oncternal Therapeutics Inc's revenue for the next 3 years is -1%.

N/A
Past Growth
-1%
Estimated Growth
Estimates Accuracy
7%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Oncternal Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Oncternal Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ONCT's stock price target?
Price Target
31.28 USD

According to Wall Street analysts, the average 1-year price target for ONCT is 31.28 USD with a low forecast of 25.25 USD and a high forecast of 40.95 USD.

What is Oncternal Therapeutics Inc's Revenue forecast?
Projected CAGR
-1%

The compound annual growth rate of Oncternal Therapeutics Inc's revenue for the next 3 years is -1%.